Tumor Uptake of Various PSMA-Targeting Tracers
| No. | Radioligand | Time after injection (min) | SUVmax | SUVmean | TBRmax/max |
|---|---|---|---|---|---|
| 1 | [68Ga]Ga-PSMA-11 | 90 (WB) | 15.3 | 4.4 | 32.6 |
| 165 | 20.0 | 4.5 | 66.7 | ||
| 240 | 17.0 | 4.0 | 38.6 | ||
| 2 | [68Ga]Ga-PSMA-11 | 90 (WB) | 3.6 | 1.7 | 359.0 |
| 165 | 5.9 | 2.9 | 295.0 | ||
| 240 | 5.8 | 2.8 | 35.9 | ||
| 3 | [68Ga]Ga-PSMA-11 | 90 (WB) | 7.4 | 2.5 | 185.3 |
| 165 | 9.8 | 2.6 | 98.4 | ||
| 240 | 10.0 | 2.8 | 26.3 | ||
| 4 | [68Ga]Ga-PSMA-11 | 90 (WB) | 6.5 | 3.1 | 10.3 |
| 165 | 9.0 | 3.5 | 17.3 | ||
| 240 | 9.0 | 3.6 | 7.5 | ||
| 5 | [68Ga]Ga-PSMA-11 | 90 (WB) | 7.3 | 1.9 | 66.6 |
| 165 | 7.7 | 2.3 | 29.5 | ||
| 240 | 9.0 | 2.6 | 64.6 | ||
| 6 | [18F]DCFPyl | 80 | 4.5 | 2.1 | 21.9 |
| NA (WB) | NA | NA | NA | ||
| 140 | 6.8 | 2.9 | 25.7 | ||
| 7 | [18F]DCFPyl | 80 | 5.3 | 2.1 | 23.5 |
| 95 (WB) | 4.5 | 2.3 | 13.6 | ||
| 140 | 7.4 | 2.7 | 24.4 | ||
| 8 | [18F]DCFPyl | 80 | 10.3 | 4.6 | 34.8 |
| 95 (WB) | 12.6 | 5.3 | 29.9 | ||
| 140 | 13.1 | 6.0 | 36.5 | ||
| 9 | [68Ga]Ga-PSMA-11 | 60 | 2.2 | 1.0 | 72.3 |
| 10 | [68Ga]Ga-PSMA-11 | 60 | 1.3 | 0.6 | 10.3 |
| 11 | [18F]PSMA-1007 | 120 | 3.4 | 1.6 | 6.1 |
| 12 | [18F]PSMA-1007 | 120 | 8.1 | 3.4 | 10.1 |
| 13 | [18F]PSMA-1007 | 120 | 14.6 | 6.8 | 39.6 |
| 14 | [18F]PSMA-1007 | 120 | 12.4 | 4.7 | 7.8 |
TBRmax/max = SUVmax tumor divided by SUVmax background; WB = whole body; NA = not available.